Juan Ren

Hangzhou, 311399, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Microglial OTUD6A promotes neuroinflammation and Alzheimer's disease pathogenesis by deubiquitinating C/EBPβ.

Microglial OTUD6A promotes neuroinflammation and Alzheimer's disease pathogenesis by deubiquitinating C/EBPβ.

Journal: Pharmacological research

Published: February 26, 2026

Tamoxifen regulates ferroptosis of hepatocytes by targeting SLC1A5 to activate hepatic stellate cells and liver fibrosis.

Tamoxifen regulates ferroptosis of hepatocytes by targeting SLC1A5 to activate hepatic stellate cells and liver fibrosis.

Journal: Chemico-biological interactions

Published: March 08, 2025

Angiotensin II-induced phosphorylation of CHK1 at serine-280 drives cardiac remodelling by direct phosphorylation of JAK1, thus activating JAK1-STAT signalling in murine cardiomyocytes.

Angiotensin II-induced phosphorylation of CHK1 at serine-280 drives cardiac remodelling by direct phosphorylation of JAK1, thus activating JAK1-STAT signalling in murine cardiomyocytes.

Journal: British journal of pharmacology

Published: February 17, 2025

Magnoflorine ameliorates hepatic fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway.

Magnoflorine ameliorates hepatic fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway.

Journal: Heliyon

Published: July 30, 2024

Ginsenoside RK3 promotes neurogenesis in Alzheimer's disease through activation of the CREB/BDNF pathway.

Ginsenoside RK3 promotes neurogenesis in Alzheimer's disease through activation of the CREB/BDNF pathway.

Journal: Journal of ethnopharmacology

Published: September 19, 2023

Ginsenoside RK1 improves cognitive impairments and pathological changes in Alzheimer's disease via stimulation of the AMPK/Nrf2 signaling pathway.

Ginsenoside RK1 improves cognitive impairments and pathological changes in Alzheimer's disease via stimulation of the AMPK/Nrf2 signaling pathway.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: April 20, 2023

Corrigendum to "circAR-E2E4-miR-665-STAT3 axis is a potential regulatory network in triple-negative breast cancer" [Heliyon 9(1), January 2023, Article e12654].

Corrigendum to "circAR-E2E4-miR-665-STAT3 axis is a potential regulatory network in triple-negative breast cancer" [Heliyon 9(1), January 2023, Article e12654].

Journal: Heliyon

Published: March 29, 2023

Doxofylline ameliorates liver fibrosis by regulating the ferroptosis signaling pathway.

Doxofylline ameliorates liver fibrosis by regulating the ferroptosis signaling pathway.

Journal: Frontiers in pharmacology

Published: December 31, 2022

Ginsenoside Rk3 ameliorates Aβ-induced neurotoxicity in APP/PS1 model mice via AMPK signaling pathway.

Ginsenoside Rk3 ameliorates Aβ-induced neurotoxicity in APP/PS1 model mice via AMPK signaling pathway.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 13, 2022

Boris knockout eliminates AOM/DSS-induced in situ colorectal cancer by suppressing DNA damage repair and inflammation.

Boris knockout eliminates AOM/DSS-induced in situ colorectal cancer by suppressing DNA damage repair and inflammation.

Journal: Cancer science

Published: August 18, 2022

BTApep-TAT peptide inhibits ADP-ribosylation of BORIS to induce DNA damage in cancer.

BTApep-TAT peptide inhibits ADP-ribosylation of BORIS to induce DNA damage in cancer.

Journal: Molecular cancer

Published: May 19, 2022

circAR-E2E4-miR-665-STAT3 axis is a potential regulatory network in triple-negative breast cancer.

circAR-E2E4-miR-665-STAT3 axis is a potential regulatory network in triple-negative breast cancer.

Journal: Heliyon

Published: February 03, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026